Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma Bone Lesions”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT01345019
What this trial is testing

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Who this might be right for
CancerHematologic MalignanciesMultiple Myeloma+3 more
Amgen 1,718
Not applicableStudy completedNCT03147326
What this trial is testing

Diagnostic Imaging of Myeloma Bone Lesions

Who this might be right for
Multiple Myeloma
Herlev Hospital 14
Not applicableUnknownNCT05381077
What this trial is testing

Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner

Who this might be right for
Multiple MyelomaBone Metastases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 30
Not applicableStudy completedNCT02800954
What this trial is testing

Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire, Amiens 111
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Large-scale testing (Phase 3)Study completedNCT00330759
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Who this might be right for
Bone Metastases
Amgen 1,779
Not applicableStudy completedNCT06838065
What this trial is testing

Rehabilitation Management for Patients with Multiple Myeloma

Who this might be right for
Multiple Myeloma Bone LesionsMultiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 128
Post-approval studies (Phase 4)WithdrawnNCT00242528
What this trial is testing

Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

Who this might be right for
Multiple Myeloma
Novartis
Not applicableStudy completedNCT01880762
What this trial is testing

Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions

Who this might be right for
Multiple MyelomaDisease of the MarrowOsteoporosis
NYU Langone Health 44
Not applicableActive Not RecruitingNCT07026799
What this trial is testing

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Who this might be right for
Multiple Myeloma Bone Lesions
University Hospital Heidelberg 50
Testing effectiveness (Phase 2)Study completedNCT00972959
What this trial is testing

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy

Who this might be right for
Multiple Myeloma
University of Athens 17
Post-approval studies (Phase 4)Study completedNCT00029224
What this trial is testing

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Who this might be right for
Breast CancerMultiple MyelomaProstate Cancer
Novartis 500
Not applicableNot Yet RecruitingNCT06988020
What this trial is testing

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma Bone Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 45
Not applicableNot Yet RecruitingNCT07388147
What this trial is testing

Exercise Therapy for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma Bone Lesions
University Hospital Heidelberg 71
Not applicableLooking for participantsNCT04533217
What this trial is testing

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Who this might be right for
Vertebral FractureMultiple Myeloma
Spine Centre of Southern Denmark 90
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT05996367
What this trial is testing

Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Instituto do Cancer do Estado de São Paulo 50
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT00424983
What this trial is testing

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

Who this might be right for
Multiple MyelomaBreast Cancer
Novartis Pharmaceuticals 18